A 28-year-old woman with a 25% TBSA circumferential full-thickness burn to both forearms develops progressive swelling and pain out of proportion to the burn depth within 6 hours of injury. Capillary refill in the distal fingers is >3 seconds, and pulses are absent on Doppler ultrasound. Which agent is the drug of choice for immediate escharotomy wound management in this patient?

## Mafenide Acetate in Escharotomy and Circumferential Burns ### Clinical Context: Compartment Syndrome in Circumferential Burns This patient has **acute compartment syndrome** secondary to a circumferential full-thickness burn. The clinical signs—progressive swelling, pain disproportionate to burn depth, absent distal pulses, and delayed capillary refill—indicate vascular compromise requiring urgent escharotomy. **Key Point:** Mafenide acetate is the drug of choice for topical antimicrobial coverage of escharotomy wounds because of its superior penetration through eschar and rapid bactericidal action. ### Why Mafenide Acetate in Escharotomy Wounds? 1. **Excellent Eschar Penetration:** Mafenide acetate penetrates full-thickness eschar and the underlying viable tissue more effectively than silver sulfadiazine, reducing the risk of burn wound infection in freshly debrided escharotomy sites. 2. **Rapid Bactericidal Activity:** Provides broad-spectrum coverage (gram-positive, gram-negative, and anaerobes) essential in the high-risk post-escharotomy period. 3. **Prevents Infection in Deep Wounds:** Escharotomy creates a large open wound with exposed subcutaneous tissue; mafenide's depth of penetration is critical. **High-Yield:** Mafenide acetate is applied immediately after escharotomy and continued until epithelialization begins or grafting is performed. ### Mechanism of Mafenide Acetate Mafenide is a sulfonamide that inhibits bacterial folic acid synthesis and cell wall formation. It is bacteriostatic and bactericidal depending on concentration. ### Comparison: Mafenide vs. Silver Sulfadiazine in Escharotomy | Feature | Mafenide Acetate | Silver Sulfadiazine | |---------|------------------|--------------------| | Eschar penetration | Excellent | Moderate | | Pain on application | Yes (significant) | No | | Metabolic effect | Acidosis (rare) | None | | Use in escharotomy | First-line | Suboptimal for deep wounds | | Use in routine burns | Cartilage only | First-line | **Clinical Pearl:** Although mafenide acetate causes pain on application (a significant drawback in routine burns), this disadvantage is outweighed by its superior penetration in escharotomy wounds, where infection risk is highest and eschar thickness is greatest. **Warning:** Do not confuse the role of mafenide acetate. It is NOT first-line for routine partial-thickness burns (where silver sulfadiazine is preferred), but it IS the agent of choice for escharotomy sites and cartilage-bearing areas.